Clinical Trial

Clinical Phenotype and Prevalence of VEXAS Syndrome in Internal Medicine

Study acronym: FIND-VEXAS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The FIND-VEXAS project is a multicenter, cross-sectional observational study conducted in Internal Medicine departments in the Friuli Venezia Giulia region of Italy. The study aims to estimate how frequently VEXAS syndrome occurs among adults older than 50 years who are admitted to Internal Medicine units with otherwise unexplained systemic inflammation or hematologic abnormalities, such as fever, elevated inflammatory markers, macrocytic anemia, thrombocytopenia, or other cytopenias. Participants will be assessed using clinical information, physical examination findings, routine laboratory tests, and imaging data. Patients with findings suggestive of VEXAS syndrome will be selected for confirmatory genetic testing of the UBA1 gene using blood or bone marrow samples. In addition to estimating the prevalence of genetically confirmed VEXAS syndrome, the study will describe the clinical manifestations, hematologic abnormalities, inflammatory profile, and organ involvement of patients with suspected or confirmed disease.
Trial Details
NCT Number NCT07708688
Lead Sponsor Centre Hospitalier Universitaire Vaudois
Collaborators: IRCCS Burlo Garofolo, FADOI-Friuli Venezia Giulia Network)
Conditions Vexas Syndrome
Enrollment 50 participants
Start Date 2026-07
Primary Completion 2028-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-16